These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 36015358)

  • 1. In Vitro Models of the Blood-Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals.
    Dabbagh F; Schroten H; Schwerk C
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4
    Nishihara H; Soldati S; Mossu A; Rosito M; Rudolph H; Muller WA; Latorre D; Sallusto F; Sospedra M; Martin R; Ishikawa H; Tenenbaum T; Schroten H; Gosselet F; Engelhardt B
    Fluids Barriers CNS; 2020 Feb; 17(1):3. PubMed ID: 32008573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier.
    Lazarevic I; Engelhardt B
    Fluids Barriers CNS; 2016 Jan; 13():2. PubMed ID: 26833402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
    Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of functional in vitro models of the blood-cerebrospinal fluid barrier in leukaemia research.
    Erb U; Schwerk C; Schroten H; Karremann M
    J Neurosci Methods; 2020 Jan; 329():108478. PubMed ID: 31669338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.
    Gelb S; Stock AD; Anzi S; Putterman C; Ben-Zvi A
    J Autoimmun; 2018 Jul; 91():34-44. PubMed ID: 29627289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models.
    Hu HH; Bian YC; Liu Y; Sheng R; Jiang HD; Yu LS; Hu YZ; Zeng S
    Int J Pharm; 2014 Jan; 460(1-2):101-7. PubMed ID: 24262988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models of the choroid plexus and the blood-cerebrospinal fluid barrier: advances, applications, and perspectives.
    Schwerk C; Schroten H
    Hum Cell; 2024 Sep; 37(5):1235-1242. PubMed ID: 39103559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity.
    Verheggen ICM; Freeze WM; de Jong JJA; Jansen JFA; Postma AA; van Boxtel MPJ; Verhey FRJ; Backes WH
    Neurosci Biobehav Rev; 2021 Aug; 127():171-183. PubMed ID: 33930471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
    de Lange EC
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
    Betterton RD; Davis TP; Ronaldson PT
    Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier.
    Ikeda-Murakami K; Tani N; Ikeda T; Aoki Y; Ishikawa T
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse.
    Kung Y; Chen KY; Liao WH; Hsu YH; Wu CH; Hsiao MY; Huang AP; Chen WS
    Fluids Barriers CNS; 2022 Jan; 19(1):3. PubMed ID: 34991647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.
    Gomez-Zepeda D; Taghi M; Scherrmann JM; Decleves X; Menet MC
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31878061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The choroid plexus may be an underestimated site of tumor invasion to the brain: an in vitro study using neuroblastoma cell lines.
    Vandenhaute E; Stump-Guthier C; Lasierra Losada M; Tenenbaum T; Rudolph H; Ishikawa H; Schwerk C; Schroten H; Dürken M; März M; Karremann M
    Cancer Cell Int; 2015; 15():102. PubMed ID: 26500454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO; Benes L
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating changes in blood-cerebrospinal fluid barrier function in a rat model of chronic hypertension using non-invasive magnetic resonance imaging.
    Perera C; Tolomeo D; Baker RR; Ohene Y; Korsak A; Lythgoe MF; Thomas DL; Wells JA
    Front Mol Neurosci; 2022; 15():964632. PubMed ID: 36117909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
    Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
    J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.